Modulation of the expression of bloom helicase by estrogenic agents

11Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

We report that the expression of Bloom helicase (BLM) was up-regulated by 17β-estradiol (E2) in estrogen receptor (ER)-positive mammary tumor MCF-7 cells, but was hardly modulated in ER-negative mammary tumor MDA-MB-231 cells. ER antagonist ICI182780 blocked the E2 effect on BLM expression in MCF-7 cells. From these results we conclude that ER participates in up-regulation of BLM expression in MCF-7 cells by means of E2. Similar results were obtained when MCF-7 cells were treated with bisphenol A (BPA), an endocrine-disrupting chemical having a weak estrogenic activity. The ER binding ability of BPA is estimated at 1/1000 of E2 ability, and in this study about 1000-times more BPA was needed for the same levels of estrogenic effect of E2. The expression of cell-cycle associated genes, cdc6, MCM5, MCM2, Myt1, PCNA and AuroraA were up-regulated by E2 and BPA treatment in MCF-7 cells accompanied by up-regulation of BLM. In this BLM promoter study, Sp1 elements in the upper region of BLM modulated transcription, but were not indispensable for E2 response. Our results suggested that up-regulation of BLM expression by E2 and BPA is ER-dependent and may be responsible for repair of DNA damage caused by the genotoxicity of these estrogenic agents. © 2007 Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Iso, T., Futami, K., Iwamoto, T., & Furuichi, Y. (2007). Modulation of the expression of bloom helicase by estrogenic agents. Biological and Pharmaceutical Bulletin, 30(2), 266–271. https://doi.org/10.1248/bpb.30.266

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free